Rhonda M. Curran

431 total citations
12 papers, 337 citations indexed

About

Rhonda M. Curran is a scholar working on Pharmaceutical Science, Molecular Biology and Virology. According to data from OpenAlex, Rhonda M. Curran has authored 12 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Rhonda M. Curran's work include Advanced Drug Delivery Systems (5 papers), HIV Research and Treatment (4 papers) and Reproductive tract infections research (3 papers). Rhonda M. Curran is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), HIV Research and Treatment (4 papers) and Reproductive tract infections research (3 papers). Rhonda M. Curran collaborates with scholars based in United Kingdom, Qatar and Ireland. Rhonda M. Curran's co-authors include Karl Malcolm, Gavin P. Andrews, A. David Woolfson, Ryan J. Morrow, Louise Donnelly, Robin J. Shattock, Christopher T. Elliott, David S. Jones, Paul F. McKay and Linda Stewart and has published in prestigious journals such as Journal of Controlled Release, Biomacromolecules and International Journal of Pharmaceutics.

In The Last Decade

Rhonda M. Curran

12 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rhonda M. Curran United Kingdom 9 139 69 66 48 47 12 337
Alexandra B. Sassi United States 10 130 0.9× 51 0.7× 140 2.1× 137 2.9× 63 1.3× 10 562
Bradley J. Catalone United States 9 22 0.2× 58 0.8× 70 1.1× 94 2.0× 75 1.6× 15 352
Shendra R. Miller United States 9 20 0.1× 52 0.8× 61 0.9× 118 2.5× 89 1.9× 10 405
Nazia Hassan India 11 59 0.4× 36 0.5× 83 1.3× 14 0.3× 60 1.3× 43 449
Ryan J. Morrow United Kingdom 10 123 0.9× 43 0.6× 55 0.8× 136 2.8× 86 1.8× 12 522
Jennifer J. Peters United States 16 124 0.9× 24 0.3× 34 0.5× 75 1.6× 106 2.3× 28 531
Laura J. Dunphy United States 9 69 0.5× 69 1.0× 158 2.4× 53 1.1× 70 1.5× 12 454
Anthony S. Ham United States 11 108 0.8× 25 0.4× 63 1.0× 155 3.2× 60 1.3× 22 461
Ankit Mittal India 12 180 1.3× 86 1.2× 101 1.5× 13 0.3× 149 3.2× 54 552
J. Wilschut Netherlands 6 61 0.4× 90 1.3× 119 1.8× 10 0.2× 117 2.5× 6 365

Countries citing papers authored by Rhonda M. Curran

Since Specialization
Citations

This map shows the geographic impact of Rhonda M. Curran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda M. Curran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda M. Curran more than expected).

Fields of papers citing papers by Rhonda M. Curran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhonda M. Curran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda M. Curran. The network helps show where Rhonda M. Curran may publish in the future.

Co-authorship network of co-authors of Rhonda M. Curran

This figure shows the co-authorship network connecting the top 25 collaborators of Rhonda M. Curran. A scholar is included among the top collaborators of Rhonda M. Curran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhonda M. Curran. Rhonda M. Curran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lohan, Maria, Áine Aventin, Mike Clarke, et al.. (2018). Can Teenage Men Be Targeted to Prevent Teenage Pregnancy? A Feasibility Cluster Randomised Controlled Intervention Trial in Schools. Prevention Science. 19(8). 1079–1090. 20 indexed citations
2.
3.
McKay, Paul F., Rhonda M. Curran, Joanne McCaffrey, et al.. (2012). Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form. Vaccine. 30(17). 2778–2785. 4 indexed citations
4.
Gupta, Prem N., Rhonda M. Curran, Victoria Kett, et al.. (2012). Development of liposome gel based formulations for intravaginal delivery of the recombinant HIV-1 envelope protein CN54gp140. European Journal of Pharmaceutical Sciences. 46(5). 315–322. 33 indexed citations
5.
Lowry, Deborah, Rhonda M. Curran, Stephanie McGrath, et al.. (2012). Characterisation of protein stability in rod-insert vaginal rings. International Journal of Pharmaceutics. 430(1-2). 89–97. 11 indexed citations
6.
McKay, Paul F., Martin J. Garland, Rhonda M. Curran, et al.. (2012). Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. Journal of Controlled Release. 162(3). 529–537. 77 indexed citations
7.
Donnelly, Louise, Rhonda M. Curran, John S. Tregoning, et al.. (2011). Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms. Vaccine. 29(27). 4512–4520. 21 indexed citations
8.
Gupta, Prem N., et al.. (2010). Development of liposome-based freeze-dried rods for vaginal vaccine delivery against HIV-1. Journal of Controlled Release. 148(1). e108–e110. 5 indexed citations
9.
10.
Curran, Rhonda M., Louise Donnelly, Ryan J. Morrow, et al.. (2009). Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses. Vaccine. 27(48). 6791–6798. 39 indexed citations
11.
Andrews, Gavin P., Louise Donnelly, David S. Jones, et al.. (2009). Characterization of the Rheological, Mucoadhesive, and Drug Release Properties of Highly Structured Gel Platforms for Intravaginal Drug Delivery. Biomacromolecules. 10(9). 2427–2435. 67 indexed citations
12.
Curran, Rhonda M., E Fringuelli, D. A. Graham, & Christopher T. Elliott. (2008). Production of serotype C specific and serotype C/D generic monoclonal antibodies using recombinant HC and HN fragments from Clostridium botulinum neurotoxin types C1 and D. Veterinary Immunology and Immunopathology. 130(1-2). 1–10. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra B. Sassi Breakdown of academic impact, for papers by Bradley J. Catalone Breakdown of academic impact, for papers by Shendra R. Miller Breakdown of academic impact, for papers by Nazia Hassan Breakdown of academic impact, for papers by Ryan J. Morrow Breakdown of academic impact, for papers by Jennifer J. Peters Breakdown of academic impact, for papers by Laura J. Dunphy Breakdown of academic impact, for papers by Anthony S. Ham Breakdown of academic impact, for papers by Ankit Mittal Breakdown of academic impact, for papers by J. Wilschut
Rankless by CCL
2026